Medical management of lower urinary tract symptoms in men with benign prostatic enlargement.

Item

http://www.wikidata.org/entity/Q38098896

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Medical management of lower ur ...... benign prostatic enlargement.

@en

type

Item

label

Medical management of lower ur ...... benign prostatic enlargement.

@en

prefLabel

Medical management of lower ur ...... benign prostatic enlargement.

@en

P1476

Medical management of lower ur ...... benign prostatic enlargement.

@en

P2093

Michael Marberger

http://www.w3.org/2001/XMLSchema#string

P2860

Intraoperative floppy iris syndrome associated with tamsulosin

Effect of dutasteride on the risk of prostate cancer.

The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the Comb

Long-term treatment with finasteride improves clinical progression of benign prostatic hyperplasia in men with an enlarged versus a smaller prostate: data from the MTOPS trial

The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (Com

Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.

A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.

Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.

The influence of finasteride on the development of prostate cancer.

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.

P2888

s12325-013-0022-7

P304

309-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-013-0022-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236181384

http://www.w3.org/2001/XMLSchema#string

P6179

1036627630

http://www.w3.org/2001/XMLSchema#string

P698

23584673

http://www.w3.org/2001/XMLSchema#string